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Benzo[a]pyrene (BaP) is a ubiquitous, potent, and complete carcinogen resulting from
incomplete organic combustion. BaP can form DNA adducts but other mechanisms may
play a role in toxicity. We used a functional toxicology approach in S. cerevisiae to assess
the genetic requirements for cellular resistance to BaP. In addition, we examined transla-
tional activities of key genes involved in various stress response pathways. We identified
multiple genes and processes involved in modulating BaP toxicity in yeast which support
DNA damage as a primary mechanism of toxicity, but also identify other potential toxic-
ity pathways. Gene ontology enrichment analysis indicated that DNA damage and repair
as well as redox homeostasis and oxidative stress are key processes in cellular response
to BaP suggesting a similar mode of action of BaP in yeast and mammals. Interestingly,
toxicant export is also implicated as a potential novel modulator of cellular susceptibility.
In particular, we identified several transporters with human orthologs (solute carrier family
22) which may play a role in mammalian systems.
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INTRODUCTION
Benzo[a]pyrene (BaP) is a potent, ubiquitous, and persistent ani-
mal carcinogen as well as a probable human carcinogen (Inter-
national Agency for Research on Cancer class I carcinogen)
produced by incomplete organic matter combustion. It read-
ily distributes to soil and dust particles (Hattemer-Frey and
Travis, 1991; Chung et al., 2011). The major routes of exposure
are food, both due to endogenous contamination and cooking
chemistry, as well as ambient air (indoor and outdoor) where
vehicular exhaust and traditional combustion cooking and heat-
ing processes are the main source of BaP exposure aside from
smoking (Mitchell, 1982; Wester et al., 1990; Laurent et al.,
2002; Roseiro et al., 2011). Inhalation is the most effective
route of BaP absorption, followed by ingestion, and then der-
mal uptake; however, the largest exposure is likely by ingestion
(Wester et al., 1990; Hattemer-Frey and Travis, 1991; Edoardo,
1992; Laurent et al., 2002; Fromme et al., 2004; Moody et al.,
2007).
Once in the body, BaP preferentially distributes to the kidneys
and liver, with lower levels partitioning to the testes, brain, and
spleen (Mitchell, 1982). BaP is difficult to excrete owing in part
to its affinity for adipose tissues and its interaction with serum
proteins, both of which can cause the chemical to remain in the
body for days despite metabolic action (Shu and Bymun, 1983).
BaP is metabolized by cytochrome P-450 enzymes (CYPs) to more
excretable yet highly reactive and toxic metabolites (Baird et al.,
2005). One of these, benzo[a]pyren-7,8-dihydrodiol-9,10-epoxide
(BPDE) is thought to form DNA adducts and facilitate the
induction of cancer via guanine to thymine transversion muta-
tions, even though cancer promotion pathways remain unclear
(Kapitulnik et al., 1978; Bartosiewicz et al., 2001; Baird et al.,
2005; Hockley et al., 2009). BaP can also form hydroquinones
that undergo a redox cycle generating genotoxic reactive oxygen
species such as superoxide and hydrogen peroxide (Kim and Lee,
1997; Baird et al., 2005). Other potential mechanisms of toxi-
city and cancer promotion involve oxidative damage, immune
suppression, activation of transposons, estrogen receptor acti-
vation, and disruption of cell-signaling (Romero et al., 1997;
Vondrácek et al., 2002; Baird et al., 2005; Stribinskis and Ramos,
2006). Currently, the temporal ordering, specificity, and relative
importance of these mechanisms in BaP toxicity is not fully
elucidated.
In yeast, including S. cerevisiae, several cytochrome P-448
monooxygenase enzymes can perform Phase I metabolism on
compounds like BaP and activate them to their toxic form (i.e.,
BPDE) in a manner analogous to mammalian microsomes (King
et al., 1983; Käppeli, 1986). These yeast microsomes are indeed
similar in weight and function to those observed in other mam-
malian species, including humans, but are enzymatically less effi-
cient and the microsomes more rapidly lose activity when isolated
in vitro (Azari and Wiseman, 1981; Käppeli, 1986). Moreover, the
genetic expression of this rudimentary metabolism is not regulated
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by chemical exposure, but rather by a complex and unclear inter-
action between the presence of oxygen and the type of metabolism
the yeast is undergoing at the time of growth (King et al., 1983).
While it is clear that S. cerevisiae have the enzymatic capability to
activate BaP into the toxic metabolites observed in other organisms
including humans, the extent of activation has not been examined
in vivo and the value of using a microsomal supernatant S-9 frac-
tion solution as a metabolic adjuvant for bioactivation has not
been assessed (Käppeli, 1986).
We used a functional genomic approach in yeast to identify
the genes important for resistance or sensitivity to BaP expo-
sure. Yeast is an useful model for functional assessment of the
genetic requirements in toxicology. The yeast genome is fully
characterized, primary biological functions are conserved and the
relatively rapid reproductive rate of yeast enables exposures over
multiple generations. In addition, deletion strains were generated
through systematic insertion of “molecular barcodes” that indi-
vidually identifies each gene knockout. As a result, functional
genomic approaches in which entire sets of deletion strains can
be pooled and simultaneously assayed for growth effects are pos-
sible (Giaever et al., 2002). In contrast to correlative genomic
approaches such as transcriptomics, functional genomics directly
identifies the genes tied to a phenotypic outcome (such as growth
or toxicity). We have previously used this approach with several
toxicants and shown the capability to translate results from yeast
to mammalian systems (Jo et al., 2009a,b; Zhang et al., 2010; Ren
et al., 2011). We also performed temporal protein expression pro-
filing of yeast stress response. We used a selected set of yeast strains
expressing full-length, chromosomally tagged green fluorescent
protein fusion (GFP) proteins with genes encoding general stress
response, oxidative stress response, chemical stress response, pro-
tein stress response, and DNA stress response (Huh et al., 2003).
This approach allows measurement of real-time protein expression
changes in response to stress. The selected stress response genes are
present and highly conserved in most cell types of metazoans and
are activated at significantly lower toxicant concentrations than
those causing overt cellular injury (Kultz, 2005; Simmons et al.,
2009).
MATERIALS AND METHODS
FUNCTIONAL GENOMIC ANALYSIS
Yeast strains
Diploid yeast deletion strains based on the BY4743 background
(Invitrogen Corporation, Carlsbad, CA, USA) were used both for
the parallel analysis pools (n= 4,757) and individual strain growth
assays. For both the deletion strain pools and the individual strains,
growth assays were performed in liquid media (2% peptone, 2%
dextrose, and 1% dextrose by volume).
Yeast growth curves
In order to assay yeast response to BaP, yeast strains were grown
to mid-log phase, diluted to an optical density of 0.0165 at
600 nm (OD600), and dispensed to a 48-well plate (non-treated
polystyrene, Grenier Bio-One, Monroe, NC, USA). BaP (Sigma-
Aldrich, St. Louis, MO, USA) was subsequently added to each well
to the desired final concentration. At least two replicates for each
dose and three biological replicates for each strain were performed.
Each plate was subsequently incubated in a GENios microplate
reader (Tecan, Durham, NC, USA) set to 30˚C with intermittent
shaking and OD595 measurements at 595 nm were recorded every
15 min for 24 h. The raw absorbance data obtained was corrected
for background, averaged across replicates, and plotted against
time. Excel 2010 (Microsoft Corporation, Redmond, WA, USA)
was used to calculate the area under the curve (AUC) as a mea-
sure of growth (the outcome of interest) and to perform statistical
analyses, namely, comparing AUC values by means of Student’s
t -test, assuming constant variance between samples.
Benzo[a]pyrene stock solutions
BaP was solubilized in dimethylsulfoxide (DMSO) and the final
concentration of DMSO in the yeast media never exceeded one
percent by volume, the standard DMSO concentration at which
no observable effect occurred on yeast. Backgrounds and controls
included one percent DMSO to account for any potential effect.
The BaP stock solutions were stored in the chemical hood shielded
from light. As long as it is shielded from light, BaP is stable in
DMSO solutions, with less than 20% degradation over 3 months
at 25˚C (Dabrowska et al., 2008).
IC20 determination
Initially, using the method developed by Pierce et al. (2007), the
concentration of BaP which resulted in a 20% decrease in growth
in wild type yeast (IC20) was determined. The IC20 point was cho-
sen for its ability to affect yeast deletion strains measurably and
differentially without incurring the loss of toxicant specificity that
occurs at higher concentrations (Pierce et al., 2007).
Yeast parallel deletion analysis
Targeted inactivation of a gene, “knockout,” is often used to inves-
tigate the gene’s function. Similarly, this same technique can be
used to identify how a gene or lack thereof affects survival of a
model organism in response to a toxicant (Giaever et al., 2002).
Using a gene knockout library of S. cerevisiae strains that rep-
resent 96% of the yeast genome’s open reading frames (ORF),
we can thus determine in parallel the effect of each gene on the
growth outcome as it relates to BAP exposure (Giaever et al., 2002).
This is accomplished by way of unique DNA “molecular barcodes”
that correspond to each knockout strain. After varying time and
dose exposures to BAP, the pooled yeast knockout library cells can
then be harvested and the extracted DNA barcodes hybridized to
oligonucleotide arrays, thereby allowing for a quantitative deter-
mination and comparison of growth outcome for each individual
strain/gene (Giaever et al., 2002).
To this end, after determining the IC20, pool growth, genomic
DNA extraction, and array hybridization were conducted as
described by Pierce et al. (2007), with a few minor changes
described herein. In summary,viable homozygous diploid deletion
mutant strains of yeast (n= 4,757) were continuously subjected
to three different BaP concentrations (IC20, 50% of the IC20, and
25% of the IC20) over a growth period of 5 and 15 generations
(5G and 15G). In this way, three total biological replicates were
obtained for each dose and generation time period. After collect-
ing the cells, the genomic DNA was extracted with the YDER kit
(Pierce Biotechnology,Rockford, IL,USA). The unique barcodes in
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the DNA, specific to each yeast strain, were amplified by PCR using
a set of biotinylated primers, and the resulting products were then
hybridized to TAG4 arrays (Affymetrix, Santa Clara, CA, USA).
Differential strain sensitivity analysis
In order to investigate genes required for optimal growth of yeast in
the presence of BaP, differential strain sensitivity analysis (DSSA)
was used to identify differential growth of viable yeast knockout
strains relative to wild type yeast in the presence of the toxicant.
To this end, the data obtained from the TAG4 array was log2 trans-
formed, adjusted for signal saturation as described in Pierce et al.
(2007) as well as adjusted for mean chip background by means of
robust location and scale estimators for log2 transformed ampli-
tudes of null features (18,000 total, evenly spread on the array). To
control for variability in strain growth, results from each treatment
array were matched to data from 12 controls (5G or 15G) for analy-
sis. Treatment-control pairs were normalized with locally weighted
scatterplot smoothing (global normalization), and the difference
in growth between strains was identified using an alpha-outlier
approach (Loguinov et al., 2004). Data from three biological repli-
cates were combined, resulting in 36 treatment-control data pairs
per treatment group. Residual variances (with a robust/∗ scale esti-
mator) of log2 (treatment/control) for each 36 pairs were inspected
using box plots. The “effective pairs” were then determined by
excluding pairs with abnormally high residual variance, or with
suspected serial correlation in variability (regular patterns in the
box plots).
Significant yeast deletion strains (i.e., genes) were statistically
inferred by an exact binomial test, with the assumption that the
outcomes for each gene in all treatment-control pairs were inde-
pendent binary variables with the same probability of success for
all Bernoulli trials. For a particular gene n, outcomes were consid-
ered as “successful” if they were significant in the outlier analysis
with q-values ≤0.05 in each of all effective pairs with log2 ratios
of the same sign, simultaneously (Loguinov et al., 2004). The cor-
responding raw p values based on the exact binomial test were
then corrected for multiplicity of comparisons using a q-value
approach and only the genes with q-value ≤0.05 were consid-
ered for further analysis. This approach does not apply a scale
estimator and, as a result, it did not require between-chip pair
normalization for the statistical inference. Subsequently, a fitness
score (ave[log2{Y|X= exposed}] – ave[log2{Y|X= control}]), the
difference of the means of the (log2) hybridization signal between
exposed and control was determined for each yeast deletion strain.
Negative scores indicate sensitivity of the strain to BaP exposure;
conversely, a positive score indicates resistance to BaP exposure.
Consequently, in the case of a negative score, the gene product
deleted from that strain is likely required for resistance to the tox-
icant. Similarly, in the case of a positive score, the absent gene
product may serve to sensitize the cell to BaP (North et al., 2011).
Gene ontology
From the significant genes responsible for resistance or sensi-
tivity to BaP in yeast identified in the DSSA method described
above, overrepresented Gene Ontology1 (GO) and MIPS (Munich
1http://www.geneontology.org/
Information Center for Protein Sequences2) categories were iden-
tified to determine which specific (if any) gene clusters related to
biological characteristics were relevant to S. cerevisiae’s response to
BaP exposure (Ashburner et al., 2000; Mewes et al., 2002). To this
end, the Functional Specification resource, FunSpec3, was used in
an enrichment analysis to determine the significantly represented
GO and MIPS biological categories among the sensitive/resistant
strains (Robinson et al., 2002). We used the hypergeometric dis-
tribution of FunSpec with a p-value significance threshold of 0.01.
Selected confirmation of yeast strain significance
In order to confirm the data previously obtained, and based on the
results from the DSSA and GO,select relevant significant yeast gene
deletion strains were chosen for individual testing. Yeast growth
curves, as described above, were performed at two different BaP
concentrations (100% IC20, 25% IC20) for the chosen deletion
strains.
S-9 metabolic adjuvant
S-9 (Molecular Toxicology, Inc., Boone, NC, USA) was obtained
as 30% by volume S-9 rat liver microsome mix (NADP,d-glucose-
6-phosphate, MgCl2, and KCl co-factors; pH= 7.4 sodium phos-
phate buffer) containing all co-factors for a sustained enzymatic
in vitro metabolic activation. The S-9 was reconstituted with
nuclease-free water and stored at −20˚C. The S-9 was prepared
and mixed with the liquid YPD media immediately prior to dis-
pensing into each of the 48-well plates. The final concentration in
each well was either 1 or 2% by volume, based on a prior study
which suggested 1.85% by volume as the optimal S-9 concentra-
tion for the in vitro activation of BaP with S-9 (Hakura et al., 2001).
The yeast growth curve protocol was followed as described previ-
ously and the results controlled for background absorption and/or
toxicity due to S-9. Our statistical analysis of the results included
the use of two-way ANOVA to assess BAP by S-9 interaction as
well as the relevant Tukey post hoc tests.
PROTEOMIC ANALYSIS OF STRESS RESPONSE PATHWAYS
GFP-fused yeast strains and stress response ensemble
We employed a library of in frame GFP fusion proteins (Invitro-
gen, no. 95702) of S. cerevisiae (ATCC 201388), constructed by
oligonucleotide-directed homologous recombination to tag each
ORF with Aequrea victoria GFP (S65T) in its chromosomal loca-
tion at the 3′ end. A set of stress response pathway genes, with
a total of selected 123 ORFs in yeast, was selected to cover five
different functional categories of stress response (Table 1).
BaP solution
BaP was solubilized in dimethylsulfoxide (DMSO) as described in
Section “Benzo[a]Pyrene Stock Solutions,” with rat liver extrac-
tion S-9 (Invitrogen, Grand Island) added to obtain a final
concentration of 1.4% for bioactivation before exposure as pre-
viously discussed. Sub-cytotoxic doses from 0.01 to 1000 mg/L
(below IC5= 3198.89 mg/L, with >95% survival percentage for
24 h exposure by AUC method in Section “Yeast Growth Curves”)
were applied.
2http://mips.helmholtz-muenchen.de/genre/proj/yeast/
3http://funspec.med.utoronto.ca/
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Table 1 | Cellular stress response pathways ensemble of ORFs for toxicity response in GFP-tagged yeast.
Stress Function Pathway Protein involved
General stress response Metabolism Trehalose synthesis TPS1, TPS2, TSL1, NTH1
Osmotic stress HOG1, GPD1, SLN1, MSB2
Other metabolism GSY2, HXK1, GLK1, PFK26, FBP26
General function Signal transduction PGM2, TPK1, TPK2, CDC28
apoptosis YAP1, CDC48, CDC6, MCA1, NMA111,
Tat-D, FIS1, OYE2, YSP2
Electron and energy related COX17, COR1, CYC7, GND2
Other response (hypoxia, etc) CYC7
Oxidative stress Redox Sensor/regulon YAP1, SLN1, SKN7, MSN2
SOD SOD1
Catalase CTT1
Glutaredoxin GRX1, GRX2
Glutathione GSH1, GPX1, GTT1, HYR1, ECM38
Thioredoxin TRX2, TSA2
Others ISM1, ATM1, CCP1, PRX1
Chemical stress Membrane, cell wall and cell structure PUN1, HSP12, MSN2
ABC transporters or related PDR1, PDR3, YCF1, PDR5, SNQ2, BPT1,
ATM1
MFS transporter (H+ antiporters) FLR1, QDR2, ATR1
TPO1, AQR1, QDR3, TOP2
Antibiotic resistance YRR1, YRM1
Other detoxification Metal BSD2
Steroid ATF2
NO YHB1
Others ECM38
Protein stress Protein misfolding Heat shock related protein HSP104, HSP42, HSP78, HSP26, SSA4,
SSA3, SSE2
Cold shock TIR1, TIP1, BFR2
ER stress Sensor; transcription factor IRE1; HAC1
Degradation and vacuolar function Ubiquitin UBC5, UBC8, HSP26
Autophagy ATG1, UTH1
DNA stress DNA repair Damage signaling CHK1, MMS2
Direct repair PHR1
BER OGG1, NTG1, NTG2, UNG1, MAG1
RAD27, APN1, APN2
NER RAD1, RAD2, RAD4, RAD9, NAD14,
RAD16, RAD23, RAD30, RAD34
MMR MSH1, MSH2, MSH3, MSH6, PMS1,
MLH1, MLH2
DSB: general XRS2, MRE11
HR RFA1, RFA2, RFA3, RAD51, RAD52,
RAD54, HTA1, HTA2
NHEJ LIF1, YKU70
Real-time transcriptional analysis
A total of six dose concentrations across 6-logs below IC5 were
tested using the GFP-tagged library and shown in a heat map.
To allow for comparison, we focused our discussion mainly with
two concentrations, 10 and 100 mg/L, since these two concen-
trations are close to those used (83.26 mg/L, 20.82 mg/L) in the
deletion library investigation. This study aims to reveal the toxicity
mechanism of BAP, so dose concentrations below IC5 but suffi-
ciently high enough to lead to observable molecular disturbance
were chosen. We note that there is bio-accumulation of BAP in
organisms of four orders of magnitude on average, so cells are
likely exposed to much higher concentrations than those typically
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found in the environment (Janikowska and Wardas, 2002; Wang
and Wang, 2006).
GFP tagged yeast strains selected were grown in clear bottom
black 384-well plates (Costar) with SD medium at 30˚C until the
cultures reached early exponential growth (OD600 about 0.2–0.4).
Ten microliters of BaP-S-9 mixture was added per well to obtain
the final concentration from 1000 to 0.01 mg/L with 10× dilution.
PBS-S-9 mixture of equal volume was used as vehicle control.
Plates were put in a Micro plate Reader (Synergy H1 Hybrid
Multi-Mode, Biotek, Winooski, VT, USA) to read continuously
for absorbance (OD600 for cell growth) and GFP signal (filters
485 nm, 528 nm for protein expression) every 5 min for 2 h (with
orbital shake at high speed for 1 min before each reading). All tests
were performed in triplicate.
Data analysis
OD and GFP raw data from measurement were corrected by
background OD and GFP signal of medium control (with
or without chemicals). The protein expression for each mea-
surement is then normalized by cell number (ODcorrected) as
P = (GFPcorrected/ODcorrected). The P level was corrected with
internal control for plate normalization (details not included
here). Then the alteration in expression for a given protein at each
time point due to chemical exposure,also referred as induction fac-
tor I, was represented as I = Pexperiment/Pvehicle by corrected values.
To quantify the chemical-induced protein expression level
changes of a treatment, the real-time protein expression profile
was then integrated into the Protein Expression Level Index (PELI)
as following:
For protein i, the accumulative protein expression over their
2 h exposure period, which is directly related to its function, is
calculated as
PELIORFi =
∫ t
t=0 Idt
exposure time
,
An assay noise cut-off is determined using a signal-to-noise
ratio of 1.5. For triplicates PELIORF were evaluated by Mean± SD.
Gene ontology
Gene ontology analysis was performed with novel Network Ontol-
ogy Analysis method (NOA) for enrichment analysis to deter-
mine the significantly represented GO biological categories, and
to analyze functions of gene network, as it allows enrichment
analysis with user defined reference set (Wang et al., 2011). In
this study the whole stress library was used as the reference set,
and activated ORFs were used as test set, which is defined as
PELIORF > 1.5 based on signal-to-noise ratio of the test. A p-value
significance threshold of 0.01 was used similar to the deletion
library.
RESULTS
BaP IC20 DETERMINATION
Based on a literature search of available toxicity data and empirical
determination, we used the yeast growth curve assay to analyze the
growth response of wild type BY4743 yeast in liquid YPD media
as a function of BaP concentration by measuring OD595 every
15 min for 24 h. Total cell growth at each chemical dose was then
determined by calculating the AUC of each OD versus time growth
curve plot (Figure A1 in Appendix; Figure 1). Visual inspection of
Figure A1 in Appendix reveals that most of the BaP toxicity dose-
response is expressed later during the stationary growth phase,
following exponential growth rather than from initial exposure.
Moreover, from this assay, the BaP IC20, or exposure concentra-
tion resulting in a 20% inhibition of growth relative to the absence
of chemical treatment, was determined to be 330µM (Figure A2
in Appendix). From the IC20 value thus calculated, we defined two
other concentrations to be used subsequently in DSSA as exposure
concentrations for the pooled homozygous diploid yeast deletion
mutants exposure periods of five and 15 yeast generations (5G and
15G; Table 2).
DIFFERENTIAL STRAIN SENSITIVITY ANALYSIS
Differential strain sensitivity analysis, described in the methods,
was performed at the concentrations specified in Table 1 for 5G
and 15G exposure periods to identify genes, each represented by a
yeast deletion strain, required for resistance or sensitivity to BaP
exposure. The results from this assay indicate that the number
of yeast genes conferring resistance or sensitivity did not vary by
dose for a 5G or 15G exposure, which may be indicative of a sharp
threshold response (Figure 2). We note approximately 17-fold
more strains exhibiting BaP sensitivity relative to BaP resistance
FIGURE 1 | Average total cell growth. Average total cell growth over the
24 h period was obtained by calculating the area under the curve (AUC) for
each dose and averaging the result across three biological replicates. Bars
are standard errors of three biological replicates; significance by t -test
comparison between each two doses sequentially; *represents p<0.05.
Table 2 | Concentrations used in DSSA pooled homozygous diploid
yeast deletion mutant exposures to BaP.
Name BaP dose concentration (µM)
IC20 330
50% IC20 165
25% IC20 82.5
www.frontiersin.org February 2013 | Volume 3 | Article 316 | 5
O’Connor et al. Yeast benzo[a]pyrene genomic toxicity profiling
FIGURE 2 | Number of sensitive and resistant yeast deletion strains for
each exposure at three BaP concentrations and for five (5G) and 15
(15G) generations.
in the 5G exposure (Figure 2) while in the 15G exposure there
are more resistant strains than sensitive ones (Figure 2). Overall,
more strains responded to BaP exposure during a 5G than during
a 15G exposure (Figure 2).
We found many strains commonly sensitive or resistant in each
dose exposure group (5G or 15G) but there was a much smaller
overlap between the 5G and 15G exposures (Figure 3).
Overall, 310 yeast mutant deletion strains were resistant and
753 were sensitive to BaP under at least one of the six treatment
conditions (three doses, two time periods). Of these sensitive and
resistant strains, 209 were resistant and 528 were sensitive under at
least three treatment conditions (Tables S1–S4 in Supplementary
Material). The treatment results for the most significant deletion
strains are reported in Tables 3 and 4.
GENE ONTOLOGY
From the strains identified in Tables S1 and S2 in Supplemen-
tary Material, an enrichment analysis was performed to identify
significantly overrepresented categories of genes among the sensi-
tive/resistant strains. The overrepresented categories are summa-
rized in Table S5 in Supplementary Material. Based on the results
of Table S5 in Supplementary Material, the significance of the cate-
gories represented, and a review of BaP toxicity, we identified select
strains associated with biological categories of potential relevance
to BaP toxicity. The strains of interest are reported in Table 5,
a subset of Table S5 in Supplementary Material. Genes related
to transmembrane transport, mitigating reactive oxygen species,
and DNA repair were identified as of particular relevance to BaP
toxicity.
VALIDATION OF DSSA DATA
From the DSSA results previously described, 18 yeast deletion
strains that exhibited significant resistance/sensitivity to BaP expo-
sure were chosen to validate results using individual assays.
These 18 deletion strains were independently exposed to BaP
concentrations of 0% IC20 (0µM), 25% IC20 (82.5µM), and
100% IC20 (330µM) for 24 h, following the same protocol as the
yeast growth curve assay used to identify the IC20. Subsequently,
growth inhibition at the various concentrations was calculated in
relation to the AUC of each growth curve, in an analogous man-
ner as the IC20 determination. Results and statistical significance
of the validation analysis are included in Figure A3 in Appendix.
All of the strains tested demonstrated statistically significant inhi-
bition using at least one BaP concentration relative to the 0%
IC20 control, with the exception of ste20∆, ctt1∆, and oye2∆
whose growth inhibition was not statistically significant. More-
over, of the fifteen strains that demonstrated statistically significant
inhibition, only glr1∆, prx1∆, and yrm1∆ did not show a dose-
dependent growth inhibition response with inhibition increasing
concomitantly with dose. The strains whose sensitivity to BaP was
confirmed in this assay are the same as the bolded strain subset
listed in Table 5.
S-9 METABOLIC ACTIVATION
In order to assess if BaP activation via S-9 influences toxicity in
yeast, we performed wild type yeast growth curve assay at BaP
concentrations of 0% IC20 (0µM), 25% IC20 (82.5µM), 50% IC20
(165µM), and 100% IC20 (330µM) with S-9 extract concentra-
tions of 0, 1, and 2% by volume (Figure 4). Only the 165µM
BaP concentration showed statistically significant more growth
inhibition with increasing S-9 extract concentrations (Figure 4).
At 82.5µM, we noted a very modest but significant decrease
between the 1 and 2% S-9 but not between 0 and 1% nor 0 and
2%. No difference was seen at the highest BaP dose. Despite the
ambiguity of the effect of S-9 on BaP toxicity, there was demon-
strable statistical evidence for interaction between BAP and S-9
(p-value= 0.000323). In addition, while BAP toxicity is influenced
by S-9 in a non-additive way, the significant effect on growth is
sensitive to highly specific BAP and S-9 dose combinations, with
maximal consequence centered at 165µM BAP and 2% S-9 and
resulting in an approximately 25% growth reduction relative to
the control.
REAL-TIME PROTEIN EXPRESSION IN GFP-INFUSED STRESS PATHWAY
ENSEMBLE YEAST LIBRARY
We examined real-time differential protein expression profiles (in
comparison to control) of BaP-induced stress response over 2 h
exposure times for six different concentrations (Figure 5).
The profiles are consistent with a dose-dependent cellular
response, with varying protein activation profiles and dynamic
toxic responses at different dose concentrations. To further quan-
tify and reveal the dominant stress response categories involved
in exposure to different chemical concentrations, an expression
level rank-based protein expression enrichment analysis was con-
ducted and the results are shown in Figure 6. The proteins and
associated stress categories that had higher expression change lev-
els (ranking) were more clearly visualized, indicating that the
cellular response shifted with concentration change, from DNA
stress at low levels to chemical and protein stress at higher
levels, and general stress response for the highest level. At rel-
atively lower dose concentration (<0.1 mg/L), DNA damage
repair pathways, primarily base excision repair, were activated. As
the dose increases, stress response activation shifts to transport
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FIGURE 3 | Venn diagrams of the amount and overlap of sensitive/resistant strains observed across overall exposure duration categories (A) and for
each dose group (B).
and membrane function, including a wide-ranging activation
of the ABC and MFS transporters involved in chemical export.
In addition, the protein stress response, including a series of
heat shock proteins involved in recognition and repair of dam-
aged/misfolded proteins, is activated. Finally, there is evidence
of oxidative damage as indicated by activation of oxidant sen-
sors and enzymes (SLN1, TRX2, and GSH1). At higher concen-
tration (>100 mg/L), stress responses shifted to more general
stress and were down regulated, while proteins for apoptosis
increased, suggesting that cells transitioned from stress response
to cell death.
According to the signal-to-noise ratio defined, 24 proteins were
activated by a 10 mg/L BaP exposure and 14 proteins for 100 mg/L
of BaP. An enrichment analysis was performed based on GO cat-
egories to identify significantly overrepresented categories among
these activated ORFs, with the whole stress library selected as the
reference in Table 6. The results suggested that the main biological
process induced by a 10 mg/L BaP exposure focused on transmem-
brane transport and protein folding. Comparison of the activated
proteins in the stress response GFP-tagged library with sensitive
genes in the deletion library showed that there were few com-
mon proteins, possibly related to the difference in testing period
(1G versus 5G) and the approach applied (protein expression ver-
sus gene deletion). Also, the GFP-tagged library only focused on
stress response with limited ORFs tested (123 ORFs in the GFP-
tagged library versus 4,757 ORFs in the gene deletion library), so
there may a significant amount of sensitive genes not tested in the
GFP-tagged library.
DISCUSSION
Although, BaP is a potent carcinogen, our understanding of its
toxicity pathways is limited. Indeed, the toxicant can form DNA
adducts and reactive oxygen species metabolites that are thought
to be the main mechanisms of toxicity. However, these pathways
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Table 3 |Table of the 25 most sensitive yeast strains exhibiting
significantly negative log2 values during a 5G exposure treatment.
Treatment
5G
82.5µM 165µM 330µM
Yeast gene
name
Open reading frame/
Yeast deletion strain
25% IC20 50% IC20 100% IC20
GAT1 YFL021W −5.6 −5.5 −5.7
GRX6 YDL010W −4.7 −4.6 −4.7
RPL33B YOR234C −4.6 −4.6 −4.6
YBR138C −4.5 −4.6 −4.6
YFL019C −4.6 −4.4 −4.6
YBL065W −4.4 −4.1 −4.4
PGM2 YMR105C −4.2 −4.3 −4.2
ECM3 YOR092W −4.2 −4.1 −4.3
MRPL39 YML009C −4.3 −4.1 −4.2
YML079W −4 −4.1 −4.1
YNL217W −4 −4.1 −3.8
DCS2 YOR173W −3.9 −3.9 −4
MRP2 YPR166C −3.9 −4 −3.9
TPO5 YKL174C −4 −3.8 −3.9
HRQ1 YDR291W −3.9 −3.8 −3.8
SLM2 YNL047C −3.8 −3.8 −3.9
YML119W −3.8 −3.8 −3.8
MAP1 YLR244C −3.8 −3.9 −3.7
YGL114W −3.7 −3.6 −3.7
SSF2 YDR312W −3.6 −3.7 −3.7
YJR079W −3.8 −3.5 −3.6
YJL046W −3.6 −3.7 −3.6
YOL118C −3.6 −3.6 −3.6
FMT1 YBL013W −3.6 −3.5 −3.6
YMR119W−A −3.4 −3.5 −3.5
Larger negative values indicate greater sensitivity to BaP.
do not fully account for the observed damage and it is likely that
other pathways are concurrently at play. Moreover, since DNA
adducts constitute only part of the parent BaP toxicity, the paucity
of reliable biomarkers specific to the toxicant also motivates the
identification of genes responsive to exposure. Although BaP tox-
icity was less in yeast than for human cells, this was consistent
with similar prior studies involving benzene. Resistance to BaP
seems to also increase with duration of exposure. Many of the
pathways elicited were consistent with prior BaP toxicity studies,
which identified reactive oxygen species and DNA damage, but our
study also identified solute carriers and transmembrane transport
as responsive to BaP exposure and as possible biomarkers. More-
over, addition of S-9 metabolic extract in addition to BaP had
limited to no effect on the latter’s toxicity in S. cerevisiae.
BaP LESS TOXIC TO YEAST THAN HUMAN CELLS
BaP was approximately 50–100 times less toxic in S. cere-
visiae than has been observed in cultured human cell
samples from individuals exposed to BaP (Aust et al., 1980;
Table 4 |Table of the 25 most sensitive yeast strains exhibiting
significantly negative log2 values during a 15G exposure treatment.
Treatment
15G
82.5µM 165µM 330µM
Yeast gene
name
Open reading frame/
Yeast deletion strain
25% IC20 50% IC20 100% IC20
BNA5 YLR231C −4.4 −4.4 −4.8
DMA1 YHR115C −4.2 −4.6 −4.7
AST2 YER101C −4.3 −4.4 −4.5
YML079W −4.3 −4.2 −4.6
RMD5 YDR255C −4.2 −4.2 −4.3
ACE2 YLR131C −3.3 −3.35 −5.6
NMA2 YGR010W −3.5 −4.1 −4.1
RPS4A YJR145C −3.7 −3.8 −4
PET309 YLR067C −3.7 −3.8 −4
LEM3 YNL323W −3.4 −3.7 −3.6
ECM32 YER176W −3.2 −3.7 −3.7
SRO9 YCL037C −3.3 −3.6 −3.6
YGL041C −3.2 −3.3 −3.8
TCB1 YOR086C −3.3 −3.4 −3.4
BUG1 YDL099W −3.1 −3.4 −3.6
AHP1 YLR109W −2.9 −3.5 −3.6
YNL285W −2.9 −3.1 −3.3
YMR158W-A −2.8 −3.2 −3.2
SGA1 YIL099W −2.8 −3 −3
SIS2 YKR072C −2.8 −3 −3
TGL4 YKR089C −2.9 −2.8 −3.1
GSP2 YOR185C −2.6 −3 −3
ASG1 YIL130W −2.9 −2.8 −2.8
RPI1 YIL119C −2.5 −3 −2.9
RNH203 YLR154C −2.4 −3 −3
Larger negative values indicate greater sensitivity to BaP.
Vayssier-Taussat et al., 2001). Yeast lacks certain peroxidases found
in humans, which are required to transform BaP metabolites, such
as hydroquinone, to more toxic forms (North et al., 2011). More-
over, BaP causes human cell proliferation at low levels, largely
depending on the proportion of metabolites produced, which
could introduce variability in identifying the IC20 (Burchiel et al.,
2007). In addition, although the BaP parent compound is rela-
tively stable in the environment, the toxic metabolite(s) is (are)
more reactive (Dabrowska et al., 2008). Nevertheless, the BaP
IC20 is lower than was found for the three benzene metabo-
lites hydroquinone, catechol, and 1,2,4-Benzentriol independently
tested using the same method (North et al., 2011).
We found more sensitive strains in the 5G assay and, conversely
more resistant strains in the 15G exposure. Interestingly many of
the strains that showed sensitivity in the 5G analysis were resis-
tant in the 15G assays (Figure 7). Cellular responses may increase
resistance in these yeast deletion strains over time. Indeed, there
are relatively few strains in common between the 5G resistant and
the 15G sensitive assays.
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Table 5 | Overrepresented (p-value<0.01) biological categories based on the MIPS and GO databases of the Functional Specification Instrument
for 5G and 15G exposures of select significantly resistant and sensitive strains, as well as any observed overlap strains between 5G and 15G
(Ashburner et al., 2000; Mewes et al., 2002; Robinson et al., 2002).
Category p-value Name of genes
in category
Number of genes
observed in category
Number of genes
in category
5G SENSITIVE
GO Molecular Function
Transferase activity [GO:0016740] 0.000779 KIN3 FMT1 ALG3 CST26 EHT1 DPB3 KCC4
FEN1 BUD23 MGT1 KIN1 MTQ2 AKR1 TRP4
DOT1 EMI2 HIS1 TMT1 RIM15 CMK1 YFR018C
TAN1 NAT2 CHO2 STE20 ARD1 YCK1 PFK26
HPM1 POT1 DAL7 AIM22 IKS1 TPK1 SET2
YJL218W ELM1 AAT1 TPK3 KTR2 AYT1 SHM2
RCK2 NNT1 TAL1 SUR4 ERG6 TRM9 APT1
URA5 TDA1 CPT1 ARE2 PFA4 GAS5 PKH2 PAP2
OST3 ABP140 TUM1 MEK1 SKS1 BTS1 ISR1
TAZ1 GPH1
66 611
NADPH dehydrogenase activity
[GO:0003959]
0.005429 OYE2 OYE3 2 2
GO Biological Process
Chromatin silencing at telomere
[GO:0006348]
0.002979 SWD1 DPB3 DOT1 DOT6 RAD6 ASF1 SPT10
IES3 MEC3 YAF9 SAS5
11 58
MIPS Functional Classification
Meiotic recombination
[10.01.05.03.01]
0.005619 MSH4 DST1 SAE2 RIM4 SAE3 REC104 RAD52
RAD50
8 38
Organization of chromosome
structure [42.10.03]
0.0058 SWD1 RIF1 SGF29 SPT3 DOT1 IES1 EST3 SET2
NAP1 IES3 SPT8 RAD52 YKU70 RAD50
14 90
Cytoplasm [725] 0.001171 ATS1 DRS2 CLN3 FLC2 APN2 PIN4 ALG3
SRO77 UGA2 GAL10 SCO2 RPS11B UBP14
TAT1 SLM4 RPL19A OPY1 YBR138C ARA1
ARL1 PEX32 EHT1 YBR225W UBX7 DPB3
DCC1 FRM2 FEN1 BUD23 RPN4 YDL063C
PEX19 BDF2 RPL13A CYK3 RDI1 PPH22 RTN2
YDL211C GDH2 DTD1 FMP45 PTP1 YDL241W
GRX3 KIN1 MTQ2 RSM24 COQ4 BTT1 AKR1
HNT2 ASP1 YDR336W YDR338C YPS7 TRP4
EFT2 SAC7 URH1 SIZ1 CYM1 DOT1 SSN2
YDR444W RPS18A EMI2 IRC4 GIM4 GLY1
YEL047C TCA17 DOT6 SWI4 SLX8 YER137C
RTR1 YER156C YER163C TMT1 DEG1 VTC2
BLM10 WWM1 YFL012W HSP12 LPD1 GAT1
BUD27 RIM15 RPL22B FET5 EMP47 CMK1
YFR016C LSB3 DUG1 RAD6 RPL9A SAE2 TAN1
SCM4 YGR117C NAT2 RPL24B CHO2 YHB1
GND2 RAD2 SLH1 STE20 RIM4 SNF6 ARD1
YHI9 AAP1 YCK1 OYE2 GND1 RPN10 YIL089W
PFK26 HPM1 HOS4 POT1 MET28 DAL81 YVH1
HYR1 MAD3 YJL043W TDH1 YJL055W IKS1
RPE1 SPT10 RPS21B TPK1 REE1 YJL218W
CPR7 YMR1 YJR111C YJR154W YKL070W KTI12
PMU1 RPS27A TPK3 SAC1 YKR041W NAP1
MSA2 YKR078W MLP1 YKR096W TPO1 MLH2
YLR036C SHM2 CCW12 ACE2 TFS1 HCR1
CCC1 MAP1 RCK2 NNT1 RPS30A TMA10 VRP1
NIT3 TAL1 ATG33 DIF1 RPL6B
245 2879
(Continued)
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Table 5 | Continued
Category p-value Name of genes
in category
Number of genes
observed in category
Number of genes
in category
YLR456W ERG6 TRM9 APT1 YOX1 YML079W
URA5 YMR074C PGM2 YMR114C ATG16
YMR244C-A GFD1 YKU70 TDA1 YMR295C
DYN3 ELP6 PUB1 SLM2 MLF3 OCA1 YAF9
YNL108C YNL122C JJJ1 RAD50 PDR17 CAF120
HCH1 PUS4 KRE1 SIN3 PKH2 RPS19A WHI2
VHS3 DCS2 SAS5 RPL33B ABP140 TUM1 HNT3
CAF20 RPL20B VTS1 LSP1 CHL1 TAE2 HST2
SKS1 SVL3 SRL4 ARL3 BTS1 RPL21B SSE1
GDE1 BEM4 OYE3 FLC1 NEW1 KEL3 ANT1
NCE102 GPH1 MET16 YPR174C AQY1
15G SENSITIVE
GO Molecular function
Glycine hydroxymethyltransferase
activity [GO:0004372]
0.001125 SHM1 SHM2 2 2
Pyridoxal phosphate binding
[GO:0030170]
0.002904 SHM1 ALT2 GLY1 IRC7 SHM2 BNA5 6 43
Zinc ion binding [GO:0008270] 0.004272 HIS4 ADH7 NRP1 NRG1 SAN1 AST2 GAT1
DMA1 AIR1 ASG1 GAT4 DAL81 ACE2 ECM22
CAT8 FAP1 GIS2 PFA4YRM1 ULS1
20 314
Sequence-specific DNA binding
transcription factor activity
[GO:0003700]
0.00656 GAT1 HAC1 XBP1 ASG1 GAT4 DAL81 PHD1
ECM22 CAT8 FAP1YRM1
11 138
Metal ion binding [GO:0046872] 0.009408 HIS4 ADH7 NRP1 NRG1 SAN1 GAT1 DMA1
HOP1 AIR1 ASG1 GAT4 DAL81 ELM1 ELF1
JLP1 IZH3 PDC1 EMP46 ACE2 ECM22 IRC21
CAT8 FAP1 NRK1 GIS2 FRE4 PFA4 DNL4TCB1
YRM1 ULS1 FMP30 PDH1
33 647
Sequence-specific DNA binding
[GO:0043565]
0.009413 NRG1 GAT1 HAC1 XBP1 ASG1 GAT4 PHD1
BAS1 ACE2 ECM22 CAT8 YRM1
12 165
Catalytic activity [GO:0003824] 0.009792 SHM1 HIS4 ADH7 PHO13 TRP1 ARO3 TPS2
ALT2 GLY1 AST2 IRC7 SGA1 IRC24 LAS21
YKL071W YKL107W SIS2 PDC1 SHM2 BNA5
EXG1 CDA1 GRE2 LSC1 GDB1
25 455
GO Biological Process
l-serine metabolic process
[GO:0006563]
0.001125 SHM1 SHM2 2 2
Protein ubiquitination involved in
ubiquitin-dependent protein
catabolic process [GO:0042787]
0.003238 SAN1 RMD5 UBC8 ELC1 4 19
Cell redox homeostasis
[GO:0045454]
0.003414 PRX1TRX2 POR2AHP1 GLR1 5 31
Drug transmembrane transport
[GO:0006855]
0.005065 YDR338C QDR2YRM1 3 11
Glycine metabolic process
[GO:0006544]
0.006456 SHM1 SHM2 2 4
GO Cellular Component
Membrane [GO:0016020] 0.003977 UIP3 SCS22 FIG2 MSS2 RGT2 RTN2 UGA4
ENT5 SPR28 OMS1 YDR338C ATP17 QCR7
YEA4 PIC2 YFR012W QCR6 KEX1 YPT32 TRX2
PHB2 APL6 PUT2 HXT1 CBR1 FIS1 KTR7
YIL089W SLM1 POR2 QDR2
(Continued)
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Table 5 | Continued
Category p-value Name of genes
in category
Number of genes
observed in category
Number of genes
in category
ATG32 DAL4 LAS21 NUP100 YKL107W PXA2
CAF4 GAP1 TGL4 SPO75 YEH2 IZH3 PET309
EMP46 EMP70 ENT2 ECM22 YLR283W NUP2
SMA2 PLB1 YET2 ATP25 AIM36 INP2 YMR166C
MFA2 LEM3 ATO2 FRE4 PFA4 TIR4 VPS5 TCB1
KTR1 FMP30 COX11 ATG5 UIP4 FLC1 SAM3
JID1 YPR174C
74 1671
MIPS Functional Classification
C-1 compound anabolism
[01.05.05.04]
0.003301 SHM1 SHM2 2 3
Detoxification by export [32.07.05] 0.003301 QDR2YRM1 2 3
Oxygen and radical detoxification
[32.07.07]
0.006587 PRX1TRX2AHP1 3 12
MIPS Subcellular Localization
Cytoplasm [725] 0.002267 UIP3 PRX1 SEA4 NGR1 FRM2 HIS4 SRO9
YCL042W ADH7 BUG1 MSS2 UBP1 LDB17
NRP1 YDL177C RTN2 DTD1 PHO13 TRP1
ARO3 NRG1 TPS2 BMH2 ALT2 GIR2 ENT5
CSN9 RMD5 YDR336W YDR338C SSN2 RMT2
UBC8 YEL043W GLY1 SAP1 AST2 ECM32 GAT1
HAC1 FAR7 QCR6 KEX1 YPT32 NMA2 ASN2
YGR153WTRX2 APL6 EFM1 ARD1 DMA1
LSM12 TDA11 AIR1 YIL089W XBP1 SLM1 RPI1
DJP1 DAL81 IRC24 RPS4A YKL063C YKL071W
YKL091C YKL107W TPK3 NAP1 TRM2 SIS2
TGL4 YLR031W PDC1 SHM2AHP1 ACE2
RNH203 YKE2 CPR6 ECM22 BNA5 RPN13
DAK1 YML079W PLB1 IRC21 RPL15B
YMR124W YMR147W ATG16 YMR166C ZDS1
CAT8 PUB1 NRK1 NPR1 GIS2 LEM3 SSK2
PKH2 GRE2 SHE4 CKA2 VPS5 EFT1YRM1
GSP2 PAC1 TAE2 ELC1 GLR1 RTT10 UIP4 FLC1
PDH1 YPR174C GDB1
118 2879
MIPS Protein Complexes
Complex Number 160 [550.2.160] 0.000146 AHP1 MEC3 DNL4 3 4
15G AND 5G SENSITIVE OVERLAP
GO Molecular Function
d-tyrosyl-tRNA(Tyr) deacylase
activity [GO:0051500]
0.004998 DTD1 1 1
Glycine hydroxymethyltransferase
activity [GO:0004372]
0.009971 SHM2 1 2
GO Biological Process
d-amino acid catabolic process
[GO:0019478]
0.004998 DTD1 1 1
l-serine metabolic process
[GO:0006563]
0.009971 SHM2 1 2
MIPS Protein Complexes
Complex Number 2, probably cell
cycle [550.1.2]
0.009971 DTD1 1 2
All strains included in this analysis were sensitive in at least one of the six treatments. Bolded genes correspond to those whose response to BaP was confirmed by
individual exposure of the corresponding deletion strain.
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FIGURE 4 | Wild type yeast exposure to various combinations of BaP and S-9 concentrations. *Indicates significance at 0.01<p<0.05, **indicates
significance at p< 0.01. Bars are standard errors of three biological replicates.
GENE ONTOLOGY AND CONFIRMATIONS: DELETION AND GFP-TAGGED
LIBRARY EXHIBIT CONCORDANT MECHANISMS OF TOXICITY AND
DETOXIFICATION
Following from the enrichment analysis of the sensitive/resistant
strains and activated ORFs, we identified four biological cat-
egories relevant to BaP toxicity. Namely, we found genes
related to cellular oxidative stress, DNA damage and repair,
and drug transmembrane transport and detoxification by export
to be implicated in the response to BaP in both dele-
tion and GFP-tagged libraries. While the toxicity pathways
are similar to what has been identified in prior studies of
BaP, the implication of transmembrane transport is novel
and could prove useful in identifying future biomarkers of
exposure.
Cellular oxidative stress and protein stress
BaP perturbs cellular redox homeostasis by producing
quinones (BaP 6,12-quinone, BaP 6,12-hydroquinone, BaP 3,6-
hydroquinone, BaP 3,6-quinone; Miller and Ramos, 2001). Fur-
ther reduction of the quinones creates reactive oxygen species
(ROS) in the form of superoxide and hydrogen peroxide (Miller
and Ramos, 2001). From our results, we observe a perturba-
tion of the cell redox homeostasis, as indicated by the sensi-
tive deletion strains related to oxygen and radical detoxification
(PRX1, TRX2, and AHP1), cellular redox homeostasis (PRX1,
TRX2, POR2, AHP1, and GLR1), and enzymes necessary for glu-
tathione – involved in mitigating oxidative stress – recycling
(OYE3). It is important to note that the genes responsible for
glutathione recycling were only significant in the 5G assay, indi-
cating that NADPH recycling is more important in reducing
oxidative stress for earlier generations, as was also found for the
quinone metabolites of benzene in a prior yeast study (North
et al., 2011). This is further confirmed by the activated oxida-
tive stress ORFs in the GFP-tagged library, such as SLN1 and
TRX2 in the 10 mg/L exposure, which imply that oxidative stress
plays an important role in BaP toxicity. In addition, protein stress
was observed in the GFP-tagged library as indicated by activation
of protein folding and refolding categories for unfolded pro-
teins such as HSP104, SSE2, SSA4, UBC8, etc., in five of the six
concentrations. However, genes involved in response to protein
misfolding were not observed in the deletion library, suggesting
that the misfolding damage may be a temporary subsequent
response of oxidative or chemical stress or that sufficient redun-
dancy exists to mitigate the requirement for any particular gene
product.
DNA damage and repair
Many of the confirmed deletion strains that exhibit sensitivity
to BaP are associated with DNA damage and cell cycle disrup-
tions that are concordant with observations in human in vitro
studies. Indeed, in S. cerevisiae, RAD6, a ubiquitin-conjugating
enzyme also involved in post-replicative repair, RAD50, impli-
cated in the repair of double-stranded DNA breaks and
homologous/non-homologous end-joining, DNL4, a DNA ligase
for non-homologous end-joining, and ELC1, important in polyu-
biquitylating Rpb1 during global genome repair, were required
for yeast tolerance to BaP (Jentsch et al., 1987; Chen et al.,
2001; Hoege et al., 2002; Zhang and Paull, 2005; LeJeune et al.,
2009). Non-homologous and homologous end-joining are known
as the most important aspect of repairing BaP-induced DNA
adducts in humans, so the significance of DNL4 in yeast sug-
gests some concordance in response to BaP (Natarajan and Palitti,
2008). Moreover, other genes in yeast appear to be important in
responding to other types of DNA damage caused by ROS (e.g.,
hydroquinones) such as DTD1, involved in nonsense mutation
suppression and ELC1, involved in global genomic repair (von
der Haar and Tuite, 2007; LeJeune et al., 2009). While SHM2 is
important in yeast for synthesizing DNA bases and its homozy-
gous deletion actually promotes resistance to most other toxicant
surveyed in other studies, this was the reverse for BaP (Huang
et al., 2008). Indeed, both direct and indirect BaP interference
with DNA replication and repair are sources of cellular growth
inhibition in yeast (Xie et al., 2003). In the GFP-tagged library,
DNA stress response is stronger at lower concentrations, e.g.,
activation of double strand break repair (RAD51 and HTA2)
for a 10µg/L exposure. For 10 mg/L, only base excision repair
(OGG1 and APN2) were activated for base damage repair related
to base oxidation, suggesting the DNA damage induced by BaP at
higher concentration focuses on bases, possibly related to oxidative
damage.
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FIGURE 5 | Real-time protein expression profile of BaP exposure
based on natural log of induction factor. ln I as average of triplicate,
Red spectrum colors indicate upregulation, green spectrum colors
indicate downregulation in yeast. X -axis bottom: testing time, every
5 min for 2 h. Y -axis left: clusters of proteins by stress response
pathways, Y -axis right: ORFs tested.
Drug transmembrane transport and detoxification by export
Two yeast strains lacking drug transmembrane transport and
detoxification by export, qdr2∆, and yrm1∆ demonstrated
significant growth inhibition in the presence of BaP. Both of
these genes encode solute carriers (from family 22) and orthologs
were noted to be upregulated in response to bisphenol A and
benzo[a]pyrene in the livers of other organisms such as rats
and mice as well as human cell cultures (Staal et al., 2006).
Moreover, the expression of such genes has been proposed as a
potential biomarker of exposure to chemicals and is an impor-
tant response to chemical injury in human liver cells (Borlark,
2005). In both yeast and people, these solute carriers are specific
to various organic anion molecules including glutathione, sulfate,
and glucuronide conjugates, which are the ultimate products of
BaP metabolism prior to excretion in humans (Pritchard et al.,
2005). Interestingly, other solute carrier families have been impli-
cated in human BaP toxicity, such as SLC38A5 which is thought to
indirectly favor cis DNA adduct formation by increasing the chlo-
ride ion concentration thus catalyzing SN2 attack of the BPDE
carbocation metabolite (Wolfe et al., 1994). However, literature
concerning the role of solute family 22 in human BaP toxicity
is limited and warrants further investigation given the poten-
tial role played by the orthologous gene in yeast BaP exposure
and hydroquinone metabolite toxicity (Keum et al., 2006). Sim-
ilarly, in the GFP-tagged assay, the two hour 10 mg/L exposure
also demonstrated strong activation of proteins for detoxification
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FIGURE 6 | Enrichment analysis of protein expression according to various stress groups for different concentrations of BaP exposure. For each
concentration, the ORFs are ranked in decreasing order by their PELI score (PELIORF, average of triplicates). Different colors indicate different stress groups (see
Table 1).
by export, including transmembrane transport (such as ATM1,
BPT1, QDR2, etc.) and transport (GLK1, TRX2, ATM1, etc.),
which supports chemical export as a significant detoxification
mechanism.
LACK OF GROWTH RESPONSE TO S-9 METABOLIC ADJUVANT AND BaP
DOSE COMBINATIONS
The combination of rat S-9 and BaP did not seem to alter growth
inhibition in wild type yeast. Only the two percent by volume
addition of rat S-9 had any significant effect, but this was only
observed at the two lowest concentrations and only resulted in
a maximum 1.3-fold increase in toxicity. Our results are con-
sistent with the study by Hakura et al. (2001) that found a
minimum concentration of approximately 1.85% S-9 by volume
was needed to metabolize BaP. Indeed, 2% S-9 increased tox-
icity significantly more than would be expected from the 1%
concentration, as illustrated by the statistical interaction between
BAP and S-9 in our study. Rat S-9 is approximately 100 times
more potent than S-9 reagents derived from human microsomes,
so we would not expect human S-9 to increase the bioactiva-
tion of BaP and toxicity in yeast (Hakura et al., 2001). Very
few studies have assayed the utility of S-9 in yeast; indeed,
one study involving chlorinated ethylenes found no difference
between treatments with and without S-9 (Koch et al., 1988).
One possibility for the observed inconsistent effect of S-9 may
be that the metabolites produced are more reactive and may
not be able to effectively enter the yeast cells. The milieu (i.e.,
within yeast cells or in solution) where the BaP metabolism
reaction occurs may also influence the amount and ratio of the
metabolites produced and absorbed by yeast cells (Käppeli, 1986).
Moreover, yeast cytochromes produced as part of the biosyn-
thesis pathway for ergosterol, which is an important component
of yeast membranes, have been shown to be able to metabolize
exogenous chemicals as a side reaction (Alexander et al., 1974;
Aoyama and Yoshida, 1978). Specifically, these enzymes are capa-
ble of oxidizing compounds to the toxic quinones and epoxides,
which are products of BAP metabolism (Wiseman et al., 1978).
In addition, these enzymes have also been shown to metabo-
lize pro-carcinogens to their carcinogenic form (Callen et al.,
1980). Consequently, while S. cerevisiae does not have the ded-
icated bona fide metabolism observed in higher organisms, some
of its biosynthetic pathways may serve this purpose. Given our
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Table 6 | Overrepresented (p-value<0.01) biological categories based on GO databases for a two hour exposure at 10 mg/L and 100 mg/L BaP in
yeast (test set) with PELIORF >1.5, with the stress library serving as a reference set.
Category p-value Names of genes
in category
Number of genes
observed in category
Number of genes
in category
10 mg/L BaP EXPOSURE
GO Molecular
Function
Unfolded protein
binding [GO:0051082]
0.0033 HSP104 HSP42 SSE2 SSA4 SSA3 5 7
GO Biological Process
Transmembrane
transport [GO:0055085]
1.20E−04 ATM1 BPT1 QDR2 TPO1 AQR1 YRM1
HSP78 SSA4 SSA3
9 14
Protein folding
[GO:0006457]
2.10E−04 HSP104 HSP78 HSP42 SSE2 SSA4 SSA3 6 7
Transport [GO:0006810] 0.0025 GLK1 TRX2 ATM1 SNQ2 BPT1 QDR2
TPO1 AQR1 YRM1 HSP78 SSA4 SSA3
12 30
Protein refolding
[GO:0042026]
0.007 HSP104 HSP78 SSE2 3 3
Intracellular protein
transmembrane
transport [GO:0065002]
0.007 HSP78 SSA4 SSA3 3 3
Establishment of
localization [GO:
GO:0051234]
0.007 GLK1 TRX2 ATM1 SNQ2 BPT1 QDR2
TPO1 AQR1 YRM1 HSP78 SSA4 SSA3
12 33
GO Cellular
Component
Integral to membrane
[GO:0016021]
0.0044 SLN1 MSB2 ATM1 SNQ2 BPT1 QDR2
TPO1 AQR1 ATF2
9 20
Intrinsic to membrane
[GO:0031224]
0.001 SLN1 MSB2 ATM1 SNQ2 BPT1 QDR2
TPO1 AQR1 ATF2
9 22
100 mg/L BaP EXPOSURE
GO Biological Process
Cytoskeleton
organization
[GO:0007010]
0.0090 DC48 HSP42 2 2
FIGURE 7 | Venn diagram overlap between sensitive and resistant strains across generations.
inconclusive results on the effect of S-9 on the toxicity of BAP,
the known reactivity of the mammalian BAP metabolites, and
the demonstrated metabolic action of endogenous yeast enzymes,
S-9 may not be necessary for bioactivation in yeast, at least for
this particular toxicant. It is also important to note, that the
specific metabolites generated by the yeast system may not be
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Table 7 | Select yeast genes with significant response to BaP and their
human orthologs.
Yeast gene Human gene Name of human gene
POR2 VDAC1 Voltage-dependent
anion-selective channel protein 1
RAD50 RAD50 DNA repair RAD50
DNL4 LIG4 DNA ligase 4
RAD6 UBE2B Ubiquitin-conjugating enzyme
E2B
SHM2 SHMT2 Serine
hydroxymethyltransferase,
mitochondrial
DTD1 C14orf126 (DTD1) d-tyrosyl-tRNA(Tyr) deacylase 1
AHP1 PRDX5 Peroxiredoxin-5, mitochondrial
GLR1 GSR Glutathione reductase
QDR2 SLC22A3, SLC22A6,
SLC22A17, SLC22A12,
SLC22A9, SLC22A1,
SLC22A5, SLC22A11
Solute carriers
SV2B Synaptic vesicle protein
TRX2 Thioredoxin domain containing
protein 3, 8, and 2 isoform 1;
thioredoxin isoform 1
PRX1 PRDX6 Peroxiredoxin-6
ELC1 TCEB1 Transcription elongation factor B
polypeptide 1
CTT1 CAT Catalase
identical to mammalian metabolites. Nevertheless, the statisti-
cally demonstrable interaction between BAP and S-9 suggests that
using S-9 bioactivation, especially at concentrations of at least
2% by volume, may prove useful for other compounds whose
independent toxicity is more subtle or ambiguous. Alternatively,
anaerobic, high glucose concentrations (4–20%), inhibitors of
mitochondrial protein synthesis, or respiration-impaired mutants
have been shown to favor cytochrome production in S. cerevisiae
and these conditions could also be used as part of a model for
investigating other bio-activated toxicants (Wiseman and King,
1982).
HUMAN ORTHOLOG GENES TO YEAST SENSITIVE/RESISTANT GENES
SUGGEST POSSIBLE BIOMARKERS
From the sensitive and resistant genes, we identified orthologous
human genes using the YOGY database (Table 7; Penkett et al.,
2006). VDAC1 has been found to be involved in the cellular apop-
totic response to BaP in mice, rats, and human cell lines (Huc et al.,
2007; Andreau et al., 2012). Perez et al. (2008) did not find RAD50
expression to be upregulated by BaP exposure in normal human
keratinocytes, but Brevik et al. (2012) determined that paternal
exposure to BaP did up-regulate expression in mouse embryos. In
this instance, RAD50 may serve as a biomarker of developmental
toxicity and exposure to the toxicant. While SHMT2 has been
implicated in tumor genesis in mice, no prior study has linked
it to BaP exposure directly (Nilsson et al., 2012). Similarly, LIG4
upregulation has been associated with tobacco-related cancers and
not BaP specifically, though BaP is a component of tobacco smoke
(Wu et al., 2004). In addition, rodent studies of rats and mice
found ortholog upregulation of UBE2B and PRDX5 as well as
downregulation of DTD1 (Chen et al., 2001; van Kesteren et al.,
2011). While none of the genes in Table 7, with the exception of
select solute carriers previously discussed and VDAC1, have been
conclusively linked to adverse outcomes in human cells and BaP
exposure, they represent candidate susceptibility loci as they are
related to carcinogenesis pathways.
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APPENDIX
FIGURE A1 | Growth curve assay for BY4743 wild type S. cerevisiae exposed to increasing concentrations of BAP inYPD liquid media. Optical density
at 595 nm was measured every 15 min for a period of 24 h; each point in the curve represents a mean of three replicates. Standard error is omitted for clarity.
FIGURE A2 | BAP Dose-response curve. Each “bp” green x mark is a point estimate of three biological replicate exposures at five concentrations: 100, 200,
300, 400, and 500µm. The dotted line represents 95% confidence interval to the fitted line. See Figure A1 for growth curves and total growth data for each of
the five doses.
www.frontiersin.org February 2013 | Volume 3 | Article 316 | 19
O’Connor et al. Yeast benzo[a]pyrene genomic toxicity profiling
FIGURE A3 | Confirmation of inhibition of selected yeast strains exposed individually to BAP. *Represents significance at 0.01 < p < 0.05; **represents
significance at p < 0.01. Bars are standard errors.
Frontiers in Genetics | Toxicogenomics February 2013 | Volume 3 | Article 316 | 20
